BRPI0403979A - composições contendo oligossacarìdeos - Google Patents

composições contendo oligossacarìdeos

Info

Publication number
BRPI0403979A
BRPI0403979A BRPI0403979-3A BRPI0403979A BRPI0403979A BR PI0403979 A BRPI0403979 A BR PI0403979A BR PI0403979 A BRPI0403979 A BR PI0403979A BR PI0403979 A BRPI0403979 A BR PI0403979A
Authority
BR
Brazil
Prior art keywords
compositions containing
containing oligosaccharides
oligosaccharides
saccharide
pathogens
Prior art date
Application number
BRPI0403979-3A
Other languages
English (en)
Inventor
Jonathan Robert Rhoades
Robert Rastall
Glenn R Gibson
Original Assignee
Novartis Nutrition Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Nutrition Ag filed Critical Novartis Nutrition Ag
Publication of BRPI0403979A publication Critical patent/BRPI0403979A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"COMPOSIçõES CONTENDO OLIGOSSACARìDEOS". A presente invenção refere-se às composições contendo um sacarídeo para a inibição da adesão de agentes patogênicos às células de mamíferos.
BRPI0403979-3A 2003-09-19 2004-09-20 composições contendo oligossacarìdeos BRPI0403979A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0321996.1A GB0321996D0 (en) 2003-09-19 2003-09-19 Organic compounds

Publications (1)

Publication Number Publication Date
BRPI0403979A true BRPI0403979A (pt) 2006-02-21

Family

ID=29266309

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0403979-3A BRPI0403979A (pt) 2003-09-19 2004-09-20 composições contendo oligossacarìdeos

Country Status (5)

Country Link
US (2) US7842678B2 (pt)
BR (1) BRPI0403979A (pt)
GB (1) GB0321996D0 (pt)
TW (2) TWI337079B (pt)
WO (1) WO2005027663A2 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005044861A1 (en) * 2003-10-31 2005-05-19 Wyeth Holdings Corporation Polysaccharides of helicobacter pylori
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
US20060246146A1 (en) * 2005-04-29 2006-11-02 Mcmahon Robert J Method of increasing the salivary sialic acid content in a mammal
US20070166242A1 (en) * 2005-12-19 2007-07-19 Kross Robert D Oral care product and method for the reduction of dental caries through inclusion of mannan and galactomannan polysaccharides in dentifrice formulations
ATE509624T1 (de) 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
CA2722017C (en) * 2008-04-21 2016-06-07 Commonwealth Scientific And Industrial Research Organisation Method and apparatus for forming titanium-aluminium based alloys
US8425955B2 (en) * 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
SG2014014435A (en) 2009-02-24 2014-07-30 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
IT1395068B1 (it) * 2009-08-07 2012-09-05 Inalco Spa Processo per la produzione di galatto-oligosaccaridi ultrapuri
US20110189342A1 (en) * 2010-02-01 2011-08-04 Jeong Hea-Seok High-purity galactooligosaccharides and uses thereof
US9096631B2 (en) * 2010-02-15 2015-08-04 Cargill, Incorporated Epimerisation of saccharides
WO2011137249A1 (en) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US9314494B2 (en) 2012-05-25 2016-04-19 The United States Of America, As Represented By The Secretary Of Agriculture Cranberry xyloglucan oligosaccharide composition
DE102013022109A1 (de) * 2013-12-27 2015-07-02 Markus Paulmichl Oligo-(2-7)-Glucuronat umfassendes Medikament (zweite medizinische Indikation)
CN107668208A (zh) * 2017-11-13 2018-02-09 海普诺凯营养品有限公司 一种促进肠道健康的配方奶粉
EP3542641B1 (de) 2018-03-20 2023-07-12 Universität Hohenheim Lactulosehaltiges produkt sowie verfahren zur herstellung eines lactulosehaltigen produkts

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4895838A (en) * 1988-03-09 1990-01-23 Trustees Of Boston University Method for provoking angiogenesis by administration of angiogenically active oligosaccharides
US5260280A (en) * 1989-02-07 1993-11-09 Snow Brand Milk Products Co., Ltd. Bacterial toxin neutralizer
JPH0779684B2 (ja) * 1989-02-27 1995-08-30 森永乳業株式会社 ビフィズス菌増殖促進組成物
US5459257A (en) * 1993-01-11 1995-10-17 Dainippon Ink And Chemicals, Inc. Sulfated oligoglycoside acylate and antiviral agent containing the same as active ingredient
DE4330773A1 (de) * 1993-09-10 1995-03-16 Laevosan Gmbh & Co Kg Blockierung der Anlagerung von Keimen an menschliche Zellen
US20020173483A1 (en) * 1999-02-19 2002-11-21 Cho-Chou Kuo Chlamydia oligosaccharides
ES2326933T3 (es) * 1996-10-16 2009-10-21 Napo Pharmaceuticals, Inc. Formulaciones entericas de composiciones de polimeros de proantocianidina antidiarreicas.
ID22340A (id) * 1997-03-25 1999-09-30 Takeda Chemical Industries Ltd Komposisi farmasi lekat-mukosa saluran pencernaan
US5906982A (en) * 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
WO1998051302A1 (en) * 1997-05-15 1998-11-19 University Of Washington Composition and methods for treating alzheimer's disease and other amyloidoses
EP0994656B1 (fr) * 1997-07-05 2006-04-19 Societe Des Produits Nestle S.A. dessert congelé avec bactéries lactiques et fibres fermentescibles
US6013635A (en) * 1998-05-28 2000-01-11 Synsorb Biotech, Inc. Treatment of C. difficile toxin B associated conditions
WO2000006115A1 (en) * 1998-07-27 2000-02-10 Anderson Jon E Topical compositions containing sialyl sugars and their derivatives
IT1304170B1 (it) * 1998-12-15 2001-03-08 Novartis Nutrition Ag Composti organici
IT1304183B1 (it) * 1998-12-18 2001-03-08 Indena Spa Complessi di proantocianidina a2 con fosfolipidi come agentiantiaterosclerotici.
EP1062876A1 (en) * 1999-02-25 2000-12-27 Societe Des Produits Nestle S.A. Caseinoglycomacropeptides as calcification agent
JP4273277B2 (ja) * 1999-06-30 2009-06-03 大塚製薬株式会社 オリゴ糖補給組成物
HK1048232B (en) * 1999-09-07 2008-10-31 Societe Des Produits Nestle S.A. Method for improving the skin and coat of pets
GB9927603D0 (en) * 1999-11-22 2000-01-19 Nestle Sa Use of a milk protein hydrolysate in the treatment of diabetes
EP1062873A1 (en) * 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
WO2001058465A2 (en) * 2000-02-10 2001-08-16 Gregor Reid Probiotic therapy for newborns
US6260280B1 (en) * 2000-02-11 2001-07-17 Keith Rapisardi Knife with ceramic blade
DE60114778T3 (de) 2000-03-10 2012-09-27 Mars Inc. (n.d.Ges.d.Staates Delaware) Behandlung von infektionen in tieren
DE60123067T2 (de) * 2000-07-14 2007-04-12 Société des Produits Nestlé S.A. Caseinoglycomacropeptide zur inhibierung der adhäsion von pathogener flora auf der haut
US6932990B2 (en) * 2000-08-01 2005-08-23 Oryza Oil & Fat Chemical Co., Ltd. Carbohydrate absorption inhibitor and method for manufacturing the same
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
EP1355542B2 (en) * 2000-12-27 2012-04-04 N.V. Nutricia Nutritional composition with health promoting action containing oligosaccharides
IS6085A (is) * 2001-09-26 2003-03-27 Genis Ehf. Lyfjablanda með kítósan óligómerum
ITMI20020756A1 (it) * 2002-04-09 2003-10-09 Sinclair Pharma S R L Composizioni farmaceutiche topiche per il trattamento delle dermatiti
EP2272522B1 (en) * 2002-06-28 2017-09-06 Nestec S.A. Therapeutic compositions for use in prophylaxis or treatment of diarrheas

Also Published As

Publication number Publication date
TWI398254B (zh) 2013-06-11
US20060287276A1 (en) 2006-12-21
WO2005027663A2 (en) 2005-03-31
TWI337079B (en) 2011-02-11
TW200526234A (en) 2005-08-16
TW201100084A (en) 2011-01-01
GB0321996D0 (en) 2003-10-22
WO2005027663A3 (en) 2005-07-07
US7842678B2 (en) 2010-11-30
US20110021417A1 (en) 2011-01-27

Similar Documents

Publication Publication Date Title
BRPI0403979A (pt) composições contendo oligossacarìdeos
BR9912073A (pt) Composições farmacêuticas que compreendem 2-quinolonas
BRPI0818893B8 (pt) compostos de tropano, suas composições farmacêuticas, seus usos e método in vitro de inibição de hsp90 em uma célula
BRPI0411528A (pt) uso de isomalte como prebiótico
TN2010000136A1 (en) Composition comprising sphingosine 1 phosphate (s1p) receptor modulators
BRPI0818672B8 (pt) composições, composições farmacêuticas e usos de 2'flúor-2'-desoxitetra-hidrouridinas
BRPI0606318B8 (pt) composto, composição, e, uso de um composto
BR0312975A (pt) Forma cristalina de agonista de receptor adrenérgico ß2
TW200609235A (en) Tetraazabenzo[e]azulene derivatives and analogs thereof
MX2009005462A (es) Analogos de 7,8-saturados-4,5-epoxi-morfinano.
BRPI0520870B8 (pt) compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila
BR0308261A (pt) Métodos extrativos para puruficação de sucralose
BRPI0411361A (pt) composições oftálmicas contendo uma combinação sinérgica de dois polìmeros
MA30042B1 (fr) Composes calcilytiques
BRPI0920355B8 (pt) composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina
TW200621313A (en) Pharmaceutical compositions
BRPI0519414A2 (pt) composiÇço oral, composiÇço em pasta ou gel, e, mÉtodos para inibir crescimento bacteriano na cavidade oral, e para manter saéde sistÊmica
BR0311327A (pt) Composição farmacêutica contendo oxcarbazepina com liberação sustentada de um ingrediente ativo
BR0308184A (pt) Composição oftálmica compreendendo ascomicina
SG158091A1 (en) Imidazoazepinone compounds
BRPI0609322A (pt) composições abosorvìveis de alfa-cianoacrilato
MX2009008324A (es) Compuestos 6´-sustituidos que tienen afinidad con el receptor de 5-hidroxitriptamina-6.
BR0212353A (pt) Composto, composição farmacêutica, e, uso de um composto
BR0208813A (pt) Composições contendo imidazotriazinona para a aplicação nasal
CR7956A (es) Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: NESTEC S.A. (CH)

Free format text: TRANSFERIDO DE: NOVARTIS AG .

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2324 DE 21-07-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: A61K 45/06 (2006.01), A23L 33/21 (2016.01), A61K 3